TDC
Thompson Davis & Co’s Sonnet BioTherapeutics SONN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$3K | – | 710 |
|
|
2017
Q4 | $3K | Hold |
1,000
| – | – | 0.01% | 586 |
|
|
2017
Q3 | $3K | Hold |
1,000
| – | – | 0.01% | 954 |
|
|
2017
Q2 | $3K | Sell |
1,000
-9,000
| -90% | -$27K | ﹤0.01% | 943 |
|
|
2017
Q1 | $4K | Hold |
10,000
| – | – | 0.01% | 944 |
|
|
2016
Q4 | $4K | Sell |
10,000
-21,096
| -68% | -$8.44K | 0.01% | 919 |
|
|
2016
Q3 | $17K | Sell |
31,096
-281,728
| -90% | -$154K | 0.03% | 531 |
|
|
2016
Q2 | $135K | Sell |
312,824
-74,373
| -19% | -$32.1K | 0.22% | 119 |
|
|
2016
Q1 | $314K | Buy |
387,197
+5,554
| +1% | +$4.5K | 0.47% | 49 |
|
|
2015
Q4 | $381K | Buy |
381,643
+21,500
| +6% | +$21.5K | 0.54% | 34 |
|
|
2015
Q3 | $396K | Buy |
360,143
+188,633
| +110% | +$207K | 0.55% | 35 |
|
|
2015
Q2 | $424K | Sell |
171,510
-38,095
| -18% | -$94.2K | 0.49% | 33 |
|
|
2015
Q1 | $501K | Buy |
209,605
+2,218
| +1% | +$5.3K | 0.6% | 25 |
|
|
2014
Q4 | $358K | Buy |
207,387
+13,999
| +7% | +$24.2K | 0.41% | 45 |
|
|
2014
Q3 | $400K | Sell |
193,388
-2,794
| -1% | -$5.78K | 0.52% | 38 |
|
|
2014
Q2 | $514K | Buy |
196,182
+16,750
| +9% | +$43.9K | 0.74% | 27 |
|
|
2014
Q1 | $675K | Buy |
179,432
+42,646
| +31% | +$160K | 1.12% | 10 |
|
|
2013
Q4 | $735K | Buy |
+136,786
| New | +$735K | 1.11% | 16 |
|